Related Experiment Video
Updated: Jun 4, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
Cancer microRNAs: from subtype profiling to predictors of response to therapy
Elcie Chan1, Daniel Estévez Prado, Joanne Barnes Weidhaas
1Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, CT 06510, USA.
Abstract:
MicroRNAs (miRNAs) are key regulators of gene expression that regulate important oncogenes and tumor suppressors. Many miRNAs can also act as oncogenes or tumor suppressors, and thus the altered expression of miRNAs is a hallmark of many cancer types. Dysregulated miRNAs provide a potentially powerful new tool that could be used to enable the characterization of tumor environments and identify novel and important oncogenic pathways. More recently, there has been growing interest in the field of miRNAs as biomarkers of cancer risk, diagnosis and response to therapy. Understanding the associations between miRNA expression and cancer phenotypes, and the potential of miRNA profiling in clinical applications, promises to be highly rewarding in the field of cancer research.
Insights
MicroRNAs (miRNAs) are crucial gene regulators implicated in cancer. Understanding miRNA expression in tumors offers new avenues for cancer diagnosis, risk assessment, and therapy response prediction.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- MicroRNAs (miRNAs) are vital gene expression regulators.
- Aberrant miRNA expression is a hallmark of various cancer types.
- miRNAs can function as oncogenes or tumor suppressors.
Purpose of the Study:
- To explore the role of dysregulated miRNAs in characterizing tumor environments.
- To identify novel oncogenic pathways through miRNA analysis.
- To investigate the potential of miRNAs as biomarkers for cancer risk, diagnosis, and therapy response.
Main Methods:
- Analysis of miRNA expression profiles in cancer.
- Correlation of miRNA expression with cancer phenotypes.
- Evaluation of miRNA profiling for clinical applications.
Main Results:
- Dysregulated miRNAs can characterize tumor microenvironments.
- miRNA profiling holds promise for identifying oncogenic pathways.
- miRNAs show potential as biomarkers for cancer detection and treatment outcomes.
Conclusions:
- Altered miRNA expression is a significant feature of cancer.
- miRNA profiling offers a powerful tool for cancer research and clinical applications.
- Further understanding of miRNA-cancer associations will advance personalized oncology.
Related Concept Videos
MicroRNAs
MicroRNAs

